Email Alerts

Please fill out the form below to receive company press releases via email when they occur.

We're sorry, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please enable scripts in your browser and reload the page.

Choose Notifications

SEC Filings

All SEC Filings

Annual & Quarterly Reports

Current Reports

Insider Transactions

Proxy Information

End of Day SEC Filings

First Name:

Last Name:

Email:

Contact Type:

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.

Tonix is enrolling in a Phase 3 study for Fibromyalgia, and Phase 2 studies for Chronic Migraine and Major Depressive Disorder. Please visit Clinical Trials.

Email Alerts

Choose Notifications

Company Information

SEC Filings